Radio frequency

Show results for

Unknown (1164)
Proteomics (75)
Metabolomics (25)
Transcriptomics (9)
Clinical (6)
Genomics (3)
Genomic (1)
Models (1)

Organisms

Chlamydomonas reinhardtii (73)
Marchantia polymorpha subsp. ruderalis (73)
Methylocystis sp. (73)
Bothrops insularis (73)
Bothrops jararaca (73)
Bothrops jararacussu (73)
Bothrops cotiara (73)
Streptomyces coelicolor (73)
Burkholderia ubonensis MSMB22 (73)
Pseudomonas aeruginosa PA103 (73)
Artibeus jamaicensis (73)
Morchella importuna (73)
Bothrops brazili (73)
Ixodes scapularis (73)
Bothrops leucurus (73)
Bothrops moojeni (73)
Pseudomonas syringae (73)
Sclerotinia sclerotiorum (73)
Brassica napus (73)
Bothrops neuwiedi (73)
Bartonella quintana JK 31 (73)
Bombyx mori (73)
Onchocerca volvulus (73)
Klebsiella pneumoniae (73)
Homo sapiens (4)
Mus musculus (3)
Urocitellus parryii (1)
Oncorhynchus nerka (1)
Lathyrus oleraceus subsp. oleraceus (1)
Glycine max (1)

Organisms

Mus musculus (2)
Rosa x damascena (1)

Repository

pride (73)
MetaboLights (25)
biostudies-arrayexpress (7)
ENA (3)
geo (2)
jPOST (2)
dbGaP (1)
PMR (1)

Tissue

Cell culture (17)
Brain (10)
Blood plasma (8)
Permanent cell line cell (4)
Epithelial cell (4)
Hippocampus (3)
Lung (3)
Visual cortex (2)
Embryonic stem cell (2)
Cerebrospinal fluid (2)
Neuron (2)
Blood serum (2)
Heart (2)
Blood (2)
Aortic endothelial cell line (1)
Caryopsis (1)
Skeletal muscle satellite stem cell (1)
Cytotoxic T-lymphocyte (1)
Neural retina (1)
Hematopoietic stem cell (1)
HUVEC cell (1)
Skeletal muscle fiber (1)
Endothelial cell (1)
Osteoblast (1)
Pluripotent stem cell (1)
Primary neuron (1)
Neural progenitor cell (1)
Osteocyte (1)
Prostate gland (1)
Pancreas (1)

Disease

Disease free (3)
Colon cancer (3)
Colorectal Neoplasms (2)
Alzheimer's disease (2)
The most important risk factor for developing esophageal adenocarcinoma (EAC) is the presence of a Barrett esophagus (BE), a condition in which, due to chronic gastro-esophageal reflux, the epithelium of the distal esophagus has been replaced by columnar epithelium containing specialized intestinal metaplasia. Patients with low grade intraepithelial neoplasia (LGIN) are therefore kept under more close observation and/or undergo more frequent endoscopic surveillance (every 6 to 12 months). Endoscopic surveillance for BE is uncomfortable to the patient and cost-effectiveness is not evidence-based (1)
Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere (1)
Neoplasm Metastasis (1)
Neoplasms (1)
Subjective cognitive decline (1)
Kabuki syndrome (1)
Congenital disorder of glycosylation (1)
Brain glioblastoma multiforme (1)
Epilepsy (1)
Lung adenocarcinoma (1)
Pancreatic ductal adenocarcinoma (1)
Brain cancer (1)
Chronic kidney disease (1)
Trypanosomiasis (1)
Breast cancer (1)

Technology Type

Mass Spectrometry (73)
Shotgun proteomics (34)
Bottom-up proteomics (29)
Mass spectrometry (20)
Data-dependent acquisition (15)
Data-independent acquisition (5)
Mass spectrometry assay (3)
SRM/MRM (3)
NMR spectroscopy (2)
Top-down proteomics (2)
Affinity purification coupled with mass spectrometry proteomics (2)
NMR spectroscopy assay (1)
SWATH MS (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (9)
Liquid Chromatography MS - negative - reverse phase (7)
Liquid Chromatography MS - (3)
Liquid Chromatography MS - positive - hilic (3)
6550 iFunnel Q-TOF LC/MS (Agilent) (2)
Bruker (2)
Liquid Chromatography MS - alternating - reverse phase (2)
Liquid Chromatography MS - negative - hilic (2)
Cell Ranger (1)
Computational analysis using R (Seurat v5.0.0) (1)
Not applicable (1)
10x Genomics Chromium Controller (1)
Illumina NovaSeq 6000 (1)
MaXis (Bruker) (1)
Flow injection analysis MS - (1)
Liquid Chromatography MS - Alternating (LC-MS (Alternating)) (1)
MicrOTOF-Q II ESI-Qq-TOF (Bruker) (1)
Liquid Chromatography Tandem MS (LC-MS/MS) (1)
Gas Chromatography MS - positive (1)
MS Imaging - (1)
Nuclear Magnetic Resonance (NMR) - (1)
Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)

Publication Date

2025 (24)
2026 (22)
2022 (12)
2024 (11)
2021 (10)
2023 (9)
2018 (8)
2019 (4)
2020 (3)
2010 (2)
2013 (1)
2012 (1)
2008 (1)
2017 (1)

CHEBI ID

CHEBI:16919 (6)
CHEBI:16335 (4)
CHEBI:17268 (4)
CHEBI:16750 (4)
CHEBI:64568 (4)
CHEBI:64561 (4)
CHEBI:15891 (4)
CHEBI:18050 (4)
CHEBI:17895 (4)
CHEBI:64563 (4)
CHEBI:28842 (4)
CHEBI:85851 (3)
CHEBI:85705 (3)
CHEBI:85704 (3)
CHEBI:85701 (3)
CHEBI:85699 (3)
CHEBI:85698 (3)
CHEBI:64521 (3)
CHEBI:66848 (3)
CHEBI:85693 (3)
CHEBI:18066 (3)
CHEBI:30913 (3)
CHEBI:57593 (3)
CHEBI:16778 (3)
CHEBI:36281 (3)
CHEBI:17713 (3)
CHEBI:18132 (3)
CHEBI:16113 (3)
CHEBI:16424 (3)
CHEBI:16235 (3)

Metabolite Name

Stearate (3)
LysoPE(20:0) (2)
Biochanin B (2)
PI(40:3) (2)
7,12-Diketolithocholic acid (2)
PI 34:1 (2)
PC 35:0 (2)
PC 31:0 (2)
PC 40:8 (2)
PC 40:7 (2)
PC 40:4 (2)
N-gamma-Glutamyl-S-allylcysteine (2)
Orientin (2)
Diacetoxyscirpenol (2)
Dihydrokaempferol (2)
5-Hydroxy-L-tryptophan (2)
PE 36:1 (2)
PC 32:2 (2)
Corosin (2)
UDP-glucose (2)
PC(40:8) (2)
Apigenin (2)
Valine (2)
Palmitate (2)
6-Hydroxynicotinic acid (2)
Myristoylglycine (2)
PGA1 (2)
PS 36:1 (2)
PI 38:4 (2)
PI 36:4 (2)

First Public Date

2026 (1)
2024 (1)
2021 (1)

Study status

Completed (4)
Withdrawn (1)
Not provided (1)

Study type

Transcription profiling by array (5)
Interventional (5)
RNA-seq of coding RNA from single cells (1)
RNA-seq of non coding RNA (1)
Observational (1)

Release Date

2025 (155)
2022 (134)
2021 (126)
2024 (123)
2023 (117)
2020 (102)
2019 (87)
2018 (78)
2017 (57)
2015 (48)
2016 (45)
2026 (28)
2014 (23)
2013 (12)
2012 (11)
2010 (10)
2009 (4)
2008 (3)
2011 (3)
2007 (1)
2006 (1)
2005 (1)
2004 (1)
2002 (1)

Lab affiliation

DEPARTMENT OF MEDICINE, ALL INDIA INSTITUTE OF MEDICAL SCIENCES, ANSARI NAGAR, NEW DELHI-110029 (4)
Max Planck Institute for Terrestrial Microbiology Karl-von-Frisch Str. 10 35043 Marburg Germany (3)
Queensland Brain Institute, The University of Queensland, St Lucia Campus (Brisbane), QLD 4072, Australia (2)
Department of Chemistry and Chemical Biology, Harvard University (2)
Department of Genetics, Department of Radiation Oncology, Cancer Genomics Netherlands, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands (1)
Bascom Palmer Eye Institute, Department of Ophthalmology, Miller School of Medicine at University of Miami, Miami, FL 33136, USA +1 (305) 4824103 (1)
MED—Mediterranean Institute for Agriculture, Environment and Development & CHANGE—Global Change and Sustainability Institute, School of Science and Technology, University of Évora, Pólo da Mitra, Ap. 94, 7002-554 Évora, Portugal (1)
Department of Biochemistry, The University of Western Ontario, London, Ontario, Canada. Department of Chemistry, The University of Western Ontario, London, Ontario, Canada. (1)
Centre of Biopharmaceutical Science for Healthy Ageing, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand (1)
Nuffield Department of Clinical Neurosciences, University of Oxford (1)
Department of Medicine, All India Institute of Medical Sciences, Ansari Nager, New Delhi- 110029 (1)
Department of Chemistry, Michigan State University, East Lansing, MI 48824 (1)
1. Garvan Institute of Medical Research, Cancer Ecosystems Program, and The Kinghorn Cancer Centre, Darlinghurst, Sydney, New South Wales, Australia. 2. School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales (UNSW), Kensington, Sydney, New South Wales, Australia. (1)
Synapse Proteomics, Children’s Medical Research Institute, The University of Sydney, 214 Hawkesbury Road Westmead NSW 2145 Australia. (1)
Biological Chemistry and Drug Discovery, School of Life Sciences, University od Dundee, Dundee (1)
Professor and Chair, Department of Cancer Biology and Genetics The Ohio State University College of Medicine Co-Leader, Cancer Biology Program The Ohio State University Comprehensive Cancer Center (1)
Functional Proteomics Lab, National Center for Biotechnology (CNB-CSIC) (1)
Institute of Medical Microbiology, Jena University Hospital, Jena, Germany (1)
Centre for Structural Systems Biology, Leibniz Institute of Virology (LIV), Faculty V: School of Life Sciences, University of Siegen, Deutsches Elektronen-Synchrotron (DESY) (1)
Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) Beutenbergstraße 11 07745 Jena, Germany (1)
Kids Neuroscience Centre, The Children's Hospital at Westmead, Faculty of Medicine and Health, University of Sydney (1)
Lung Repair & Regeneration Department, Boehringer Ingelheim Pharma GmbH & Co. KG (1)
Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Cancer Research Centre, Wilmslow Road, Manchester M20 4GJ, United Kingdom (1)
Professor at the Section for Clinical Chemistry, Department of Translational Medicine, Lund University. Sweden (1)
Departamento de Biología de Sistemas, Universidad de Alcalá, 28871 Alcala de Henares, Madrid, Spain (1)
Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI) Beutenbergstraße 11 07745 Jena (1)
AQUACEN - National Reference Laboratory for Aquatic Animal Diseases (1)
State Key Laboratory of Medicinal Chemical Biology and Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin, China (1)
Institute of Diagnostic and Interventional Radiology, Jena University Hospital – Friedrich Schiller Uni-versity Jena, Am Klinikum 1, D-07740 Jena, Germany (1)
Leibniz Institute on Aging, Fritz Lipmann Institute, Beutenbergstrasse 11, 07745 Jena, Germany (1)